Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -366.60%-7.39B | -1,034.47%-14.26B | -50.38%-5.5B | -114.66%-34M | -1,957.93%-7.14B | -129.89%-1.58B | 109.07%1.53B | -3.66B | 232M | -347M |
Net profit before non-cash adjustment | 22.00%5.58B | 9.13%17.89B | -23.30%4.83B | -4.44%5.04B | 50.11%3.45B | 80.84%4.58B | 510.13%16.39B | --6.3B | --5.27B | --2.3B |
Total adjustment of non-cash items | -43.74%-2.11B | -56.14%1.07B | 108.05%1.86B | -185.85%-1.83B | 427.12%2.51B | -954.65%-1.47B | 108.66%2.43B | --894M | --2.13B | ---767M |
-Depreciation and amortization | -27.86%435M | -25.61%2.04B | -42.38%446M | -29.95%435M | -17.33%558M | -10.67%603M | 235.57%2.75B | --774M | --621M | --675M |
-Disposal profit | ---1.11B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 30.78%-1.44B | -212.50%-975M | 1,078.33%1.41B | -249.83%-2.27B | 235.30%1.95B | -312.13%-2.07B | -226.83%-312M | --120M | --1.51B | ---1.44B |
Changes in working capital | -131.45%-10.86B | -91.99%-33.22B | -12.39%-12.19B | 54.87%-3.24B | -597.76%-13.1B | -280.85%-4.69B | -23.58%-17.3B | ---10.85B | ---7.17B | ---1.88B |
-Change in receivables | 21.53%-11.17B | -48.16%-68.64B | 15.69%-10.04B | -76.95%-19.62B | -86.97%-24.75B | -40.97%-14.23B | -31.78%-46.32B | ---11.91B | ---11.09B | ---13.24B |
-Change in prepaid assets | -99.92%7M | 23.04%34.92B | -152.15%-960M | 235.60%16.35B | 9.74%10.83B | -26.25%8.71B | 47.70%28.38B | --1.84B | --4.87B | --9.86B |
-Change in payables | -64.30%297M | -22.20%501M | -52.69%-1.19B | 103.55%34M | -44.75%826M | -6.09%832M | 87.76%644M | ---780M | ---957M | --1.5B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -22.22%-55M | 4.27%-202M | 18.03%-50M | 12.50%-63M | -10.00%-44M | -18.42%-45M | -63.57%-211M | -61M | -72M | -40M |
Interest received (cash flow from operating activities) | 16.20%251M | 67.40%837M | -18.73%256M | 1,588.89%152M | 88.50%213M | 242.86%216M | 900.00%500M | 315M | 9M | 113M |
Tax refund paid | 75.00%-1.53B | -227.43%-9.75B | 0 | -92.39%-3.54B | -185.86%-85M | -350.59%-6.13B | 68.11%-2.98B | 122M | -1.84B | 99M |
Other operating cash inflow (outflow) | 100.18%9M | 42.40%-19.96B | 100.23%11M | 0.02%-4.99B | -104.40%-9.99B | 74.99%-4.99B | -108,403.13%-34.66B | -4.82B | -4.99B | -4.89B |
Operating cash flow | 30.43%-8.72B | -20.99%-43.34B | 34.80%-5.28B | -27.20%-8.47B | -236.72%-17.05B | 21.64%-12.53B | -36.63%-35.82B | ---8.1B | ---6.66B | ---5.06B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -338.10%-92M | 73.28%-155M | -10.00%-110M | 15.38%-11M | 89.26%-13M | 93.93%-21M | 13.30%-580M | ---100M | ---13M | ---121M |
Net investment product transactions | --0 | -812.84%-995M | -141.86%-18M | -643.75%-476M | 338.98%518M | -394.66%-1.02B | -826.67%-109M | --43M | ---64M | --118M |
Net changes in other investments | -154.44%-98M | 210.23%273M | 227.27%14M | -500.00%-6M | 158.62%85M | -26.53%180M | 8,700.00%88M | ---11M | ---1M | ---145M |
Investing cash flow | 77.91%-190M | -45.92%-877M | -67.65%-114M | -532.05%-493M | 498.65%590M | -180.13%-860M | 10.43%-601M | ---68M | ---78M | ---148M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -486.32%-18.13B | 27.11%33.28B | 95.19%10.6B | 10.88%8.36B | 90.67%9.63B | -42.49%4.69B | -56.43%26.18B | --5.43B | --7.54B | --5.05B |
Net common stock issuance | -98.33%2M | -72.84%226M | -97.24%21M | 304.76%85M | --0 | 5,900.00%120M | -60.19%832M | --761M | --21M | --48M |
Increase or decrease of lease financing | 31.58%-286M | 23.43%-1.41B | -115.38%-308M | 57.28%-346M | 15.42%-340M | 14.52%-418M | ---1.84B | ---143M | ---810M | ---402M |
Net other fund-raising expenses | 200.00%1M | ---- | ---- | --0 | --0 | ---1M | ---- | ---- | --0 | ---- |
Financing cash flow | -519.05%-18.41B | 27.51%32.09B | 70.48%10.31B | 19.97%8.1B | 97.85%9.29B | -42.74%4.39B | -59.45%25.17B | --6.05B | --6.75B | --4.7B |
Net cash flow | ||||||||||
Beginning cash position | -4.87%192B | -4.69%201.82B | -8.06%185.76B | -8.42%185.17B | -5.39%193.56B | -4.69%201.82B | 23.50%211.76B | --202.06B | --202.19B | --204.58B |
Current changes in cash | -203.67%-27.32B | -7.72%-12.12B | 331.11%4.91B | -7,990.91%-868M | -1,289.34%-7.17B | -4.33%-9B | -131.99%-11.25B | ---2.13B | --11M | ---516M |
Effect of exchange rate changes | -442.95%-2.53B | 74.56%2.3B | -29.95%1.32B | 1,098.63%1.46B | 34.91%-1.22B | -49.07%738M | -72.37%1.32B | --1.89B | ---146M | ---1.88B |
Cash adjustments other than cash changes | ---3M | ---- | ---- | ---- | ---- | ---- | 200.00%1M | ---- | ---- | ---- |
End cash Position | -16.23%162.14B | -4.87%192B | -4.87%192B | -8.06%185.76B | -8.42%185.17B | -5.39%193.56B | -4.53%201.82B | --201.82B | --202.06B | --202.19B |
Free cash flow | 29.81%-8.81B | -19.48%-43.49B | 34.25%-5.39B | -27.12%-8.49B | -229.11%-17.06B | 23.17%-12.55B | -35.39%-36.4B | ---8.2B | ---6.68B | ---5.18B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |